Ranbaxy Can't Duck Antitrust Suit Over Generic Applications
A Massachusetts federal magistrate judge recommended on Thursday that no claims be dismissed from retailer Meijer's putative class action against pharmaceutical company Ranbaxy over the allegedly unfair competitive advantage it got...To view the full article, register now.
Already a subscriber? Click here to view full article